Overview

A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg

Status:
Not yet recruiting

Trial end date:
2021-07-01

Target enrollment:

Participant gender:

Summary

Multi-center, open-label, single arm study to Evaluate the preference regarding convenience of medication, efficacy and safety of Sugamet XR tab. 5/1000mg in patients with Type 2 diabetes and renal diseases

Phase:

Phase 4

Details

Lead Sponsor:

Dong-A ST Co., Ltd.

Treatments:

Metformin